January 31, 2015 7:20 AM ET

Pharmaceuticals

Company Overview of Edusa Pharmaceuticals, Inc.

Company Overview

Edusa Pharmaceuticals, Inc. produces a compound to treat gastroesophageal reflux disease. It develops Pumosetrag, a 5-HT3 partial agonist to treat the symptoms of upper gastrointestinal dismotility. The Pumosetrag is used to treat gastroesophageal reflux disease and potentially gastroparesis symptoms in patients who continue to experience heartburn and regurgitation while on proton pump inhibitors or H2-antagonists. Edusa Pharmaceuticals, Inc. was formerly known as Dynogen Pharmaceuticals, Inc. and changed its name to Edusa Pharmaceuticals, Inc. in June 2009. Edusa Pharmaceuticals, Inc. was founded in 2002 and is based in Princeton, New Jersey.

104 Carnegie Center

Suite 214

Princeton, NJ 08540

United States

Founded in 2002

Phone:

609-916-0232

Fax:

609-275-5610

Key Executives for Edusa Pharmaceuticals, Inc.

Chief Financial Officer and Director
Chief Scientific Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Emmaus Medical, Inc. United States
Wyeth-Ayerst International, Inc. United States
Nutrilite Health Institute United States
Fidia Pharma USA Inc United States
Palkion Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Edusa Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.